Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glioblastoma | D005909 | EFO_0000515 | — | 5 | 2 | 1 | — | — | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glioma | D005910 | EFO_0000520 | — | 6 | 3 | — | — | — | 6 |
Astrocytoma | D001254 | EFO_0000271 | — | 5 | 2 | — | — | — | 5 |
Recurrence | D012008 | — | — | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Carcinoma | D002277 | — | C80.0 | 1 | — | — | — | — | 1 |
Adrenocortical carcinoma | D018268 | — | — | 1 | — | — | — | — | 1 |
Oligodendroglioma | D009837 | EFO_0000631 | — | 1 | — | — | — | — | 1 |
Drug common name | Cintredekin besudotox |
INN | cintredekin besudotox |
Description | Cintredekin besudotox is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | interleukins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108583 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | ZL04JX89M7 (ChemIDplus, GSRS) |